Biomerica reports real-world data showing IBS therapy effectiveness
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- US futures steady as oil retreats ahead of earnings deluge, Fed decision
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil slips but stays near six-month highs on Saudi attacks
- BofA flags further downside risk for stocks, yields and dollar
Biomerica Reports Real-World Data: Nearly 60% of IBS Patients Achieved Clinically Meaningful Pain Reduction and 68% Achieved Bloating Reduction with the inFoods® IBS Therapy
February 26, 2026 8:19 AM ESTKey Highlights
Responder Analysis: 59.4% of patients achieved 30% reduction in abdominal pain; 68.1% achieved 30% reduction in bloatingusing the FDA-recognized responder endpoint consistent with the Companys peer-reviewed randomized controlled trial.CMS Payment Rate: $300 national Medicare payment rate established, effective January... More


